A prospective two-year assessment of miconazole resistance in candida spp. with repeated treatment with 0.25% miconazole nitrate ointment in neonates and infants with moderate to severe diaper dermatitis complicated by cutaneous candidiasis

Pediatric Dermatology

Volumn 30, Issue 6, 2013, Pages 717-724

  Blanco, Daisy ^a   Van Rossem, Koen ^b  

^a Instituto Dermatolõgico   (Dominican Republic)

^b GSK   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

MICONAZOLE NITRATE; WHITE PETROLATUM; ZINC OXIDE;

ACARODERMATITIS; ACUTE SINUSITIS; ALLERGIC RHINITIS; AMEBIASIS; ANTIFUNGAL RESISTANCE; ARTICLE; ASTHMA; ATOPIC DERMATITIS; BRONCHITIS; CANDIDA ALBICANS; CHICKENPOX; CONJUNCTIVITIS; CONTACT DERMATITIS; COUGHING; DERMATITIS; DIAPER DERMATITIS; DIARRHEA; DISEASE SEVERITY; DRUG EFFICACY; DRUG FEVER; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EAR INFECTION; FEMALE; FOLLOW UP; HUMAN; IMPETIGO; INFANT; INFLUENZA; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTICENTER STUDY; NEWBORN; OPEN STUDY; OTALGIA; OTITIS MEDIA; PHARYNGITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY TRACT INFECTION; RHINITIS; RHINOPHARYNGITIS; SKIN CANDIDIASIS; TREATMENT DURATION; VOMITING;

ANTIFUNGAL AGENTS; CANDIDIASIS; DERMATITIS; DERMATOLOGIC AGENTS; DIAPER RASH; DRUG RESISTANCE, FUNGAL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MICONAZOLE; MICROBIAL SENSITIVITY TESTS; OINTMENTS; PETROLATUM; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; ZINC OXIDE;

EID: 84887624828     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/pde.12107     Document Type: Article

References (15)

1. Leyden JJ,. Diaper dermatitis. Dermatol Clin 1986; 4: 23-28.
2. Concannon P, Gisoldi E, Phillips S, et al. Diaper derm-atitis: a therapeutic dilemma. Results of a double-blind placebo controlled trial of miconazole nitrate 0.25%. Pediatr Dermatol 2001; 18: 149-155.
3. Spraker MK, Gisoldi EM, Siegfried EC, et al. Topical miconazole nitrate ointment in the treatment of diaper dermatitis complicated by candidiasis. Cutis 2006; 77: 113-120.
4. Eichenfield LF, Bogen ML,. Absorption and efficacy of miconazole nitrate 0.25% ointment in infants with diaper dermatitis. J Drugs Dermatol 2007; 6: 522-526.
5. Piérard-Franchimont C, Letawe C, Piérard GE,. Tribological and mycological consequences of the use of a miconazole nitrate-containing paste for the prevention of diaper dermatitis: an open pilot study. Eur J Pediatr 1996; 155: 756-758.
6. Herrera JC, Regalado E, Alcantara R, et al. Study of the efficacy and the absorption of miconazole nitrate in infants with diaper dermatitis, alone or associated with systemic pathology, Janssen Research Foundation Clinical Research Report, 1989.
7. Fallon Friedlander S, Eichenfield LF, Leyden J, et al. Diaper dermatitis: appropriate evaluation and optimal management strategies. In association with Contemporary Pediatrics 2009 [on-line]. http://www.modernmedicine.com/ modernmedicine/data/articlestandard//modernmedicine/142009/590198/article.pdf (accessed March 15, 2012).
8. ® ointment, prescribing information, 2011 [on-line]. http://www.stiefel.com/content/dam/ stiefel/globals/documents/pdf/US-Vusion-Ointment.pdf (accessed May 24, 2012).
9. Bennet JE,. Antimicrobial agents. In:, Hardman JG, Limbird LE, Molinoff PB, et al., eds. Goodman and Gilman's the pharmacological basis of therapeutics. New York: McGraw-Hill, 1996: 1175-1190.
10. Vanden Bossche H, Marichal P, Odds FC, et al. Characterization of an azole-resistant Candida glabrata isolate. Antimicrob Agents Chemother 1992; 36: 2602-2610.
11. Kerridge D, Fasoli M, Wayman FJ,. Drug resistance in Candida albicans and Candida glabrata. Ann N Y Acad Sci 1988; 544: 245-259.
12. Ghannoum MA, Herbert J, Isham N,. Repeated exposure of Candida spp. to miconazole demonstrates no development of resistance. Mycoses 2011; 54: e175-e177.
13. Dota KFD, Freitas AR, Consolaro MEL, et al. A challenge for clinical laboratories: detection of antifungal resistance in Candida species causing vulvovaginal candidiasis. Lab Med 2011; 42: 87-93.
14. Fothergill AW,. Miconazole: a historical perspective. Expert Rev Anti Infect Ther 2006; 4: 171-175.
15. Girish Kumar CP, Hanafy AM, Katsu M, et al. Molecular analysis and susceptibility profiling of Candida albicans isolates from immunocompromised patients in South India. Mycopathologia 2006; 161: 153-159.